<qa>  What is the main cause of the increase in tumor infiltrating cytotoxic T-PRIMARY OBJECTIVES I. To establish that the combination of pembrolizumab and traditional external beam multifractionated radiation therapy RT to the primary tumor or a single target metastatic site of patients with metastatic gastric, esophageal, andor gastroesophageal junction GEJ cancers will lead to an increase in tumor infiltrating cytotoxic T-cells and circulating cytotoxic T cells and a reduction in immunosuppressive regulatory T cells Tregs and myeloid-derived suppressor cells MDSCs in metastatic sites. 